President Trump may soon fire FDA Commissioner Marty Makary, according to reports from various news sources, including The Wall Street Journal. If this happens, it would add to a growing list of high-profile exits from the health department led by Robert F. Kennedy Jr.
Makary has been in this role for just over a year. His time was marked by ambitious plans, like speeding up drug approvals and cracking down on misleading advertising. However, it’s been a tumultuous period, characterized by staff turnover and claims of political pressure affecting the FDA’s scientific work. Recent speculation about his job security has circulated since late 2025, sparking concerns among industry insiders and politicians.
His departure would leave the FDA with no permanent leadership in its key divisions, which regulate the biopharma sector. Just three months ago, the Trump administration made significant changes at the Department of Health and Human Services (HHS), removing two high-ranking officials to regain control over the department.
In the middle of these developments, Makary faced challenges. Reports indicated he resisted approving flavored vapes, which upset President Trump, who sought to appeal to young voters. He also faced backlash from the anti-abortion community due to delays in a crucial safety study on the abortion pill, mifepristone.
Interestingly, this isn’t the first time a shake-up at the FDA has caused ripples. Looking back, the agency has undergone numerous leadership changes over the years, reflecting political climates and public health crises. In many cases, new leaders come in with sweeping reforms, but often leave in the wake of controversies.
Amid these challenges, industry insiders have emphasized the critical need for stability in health oversight. As of now, no official comments have come from the White House or from Makary regarding the rumors.
For more insights on FDA leadership and its implications, you can check Bloomberg News or Politico.
Source link
Congress,Donald Trump,drug development,FDA,HHS,Policy,RFK Jr.,White House
